Results 101 to 110 of about 226,492 (355)

Rare Occurrence of Herpes Zoster of Trigeminal Nerve following Extraction of Tooth

open access: yesCase Reports in Dentistry, 2015
Herpes Zoster also known as Shingles is an acute viral infection which is an extremely painful and incapacitating ailment. It results from the reactivation of the varicella zoster virus.
A. Winnifred Christy   +3 more
doaj   +1 more source

Bee products as alternatives in the treatment of viral infections

open access: yesJournal of the Science of Food and Agriculture, EarlyView.
Abstract Medicines used in the treatment of viral infections usually reduce symptoms. There is a need to develop drugs that inhibit the viruses and do not merely relieve the symptoms. Natural bee products possess many pharmacological properties and are widely used in folk medicine. There are many studies on the antibacterial effects of bee products but
Michał Otręba   +3 more
wiley   +1 more source

Systematic evaluation of the pharmacoeconomics research on herpes zoster vaccine administration: a systematic review

open access: yesZhongguo gonggong weisheng
ObjectiveTo systematically evaluate the pharmacoeconomic research on herpes zoster (HZ) vaccine administration, providing reference for related research and prevention of HZ.
Xinping LIU   +4 more
doaj   +1 more source

Examining the potential for porcine-derived islet cells to harbour viral pathogens [PDF]

open access: yes, 2018
With an onus on safety in the potential use of porcine islet cells as a treatment for diabetes, the use of animals lacking exogenous pathogens is clearly important and multilevel screening strategies have been presented on testing animals and the product.
Crossan, Claire   +4 more
core   +2 more sources

Necrodestructive herpes zoster

open access: yesIndian Journal of Dermatology, 2012
Herpes Zoster (HZ) is a self-limiting viral infection of skin and mucosa caused by Varicella zoster virus. Cutaneous lesions of HZ usually heal without any scarring and hyper/hypopigmentation. Though, post-inflammatory depigmentation and deep scarring can occur in immunocompromised or HIV positive individuals.
Kamal Aggarwal   +3 more
openaire   +3 more sources

Identifying Cellular Immunodeficiency Through a Persistent Herpetic Whitlow

open access: yesJEADV Clinical Practice, EarlyView.
ABSTRACT Cutaneous infections caused by HSV are common, with the oral and genital mucosa being most frequently affected (1, 2). In individuals with immunodeficiency, HSV‐2 caused skin lesions may appear severe and unusual, or occur simultaneously with other skin diseases (3).
Chiara L. Blomen   +4 more
wiley   +1 more source

Major Ozonated Autoheamotherapy Alleviates Skeletal Muscle Ischemia/Reperfusion Injury by Regulating Nrf2/HO‐1 Pathway

open access: yesThe Kaohsiung Journal of Medical Sciences, EarlyView.
ABSTRACT Skeletal muscle ischaemia/reperfusion (I/R) injury remains a clinically significant condition characterized by muscular dystrophy. Although ozone therapy has shown protective potential against I/R injury in animal models of various organs including skeletal muscle, its precise mechanistic underpinnings require further elucidation.
Hui‐Zhuang Guo   +2 more
wiley   +1 more source

Herpes Zoster as a Predictor of HIV Infection in Taiwan: A Population-Based Study. [PDF]

open access: yesPLoS ONE, 2015
This study aimed to investigate the association between herpes zoster (HZ) and human immunodeficiency virus (HIV). Data were retrieved from the Longitudinal Health Insurance Databases (LHID 2005 and 2010), Taiwan.
Yuan-Ti Lee   +9 more
doaj   +1 more source

Herpes Zoster Infection in Patients With Ulcerative Colitis Receiving Tofacitinib

open access: yesInflammatory Bowel Diseases, 2018
Background Tofacitinib is an oral, small molecule Janus kinase inhibitor that is being investigated for ulcerative colitis (UC). Tofacitinib is approved for rheumatoid arthritis and psoriatic arthritis, where it has been shown to increase herpes zoster ...
K. Winthrop   +9 more
semanticscholar   +1 more source

Tofacitinib in the management of active psoriatic arthritis: patient selection and perspectives. [PDF]

open access: yes, 2019
Tofacitinib is an oral Janus kinase inhibitor approved for the treatment of psoriatic arthritis (PsA). It provides an alternative option for patients who have had an inadequate response and tolerance to other disease modifying antirheumatic drugs (DMARDs)
Beck, Kristen M   +4 more
core  

Home - About - Disclaimer - Privacy